Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 33Unknown 32Recruiting 25Not yet recruiting 16Terminated 8Active not recruiting 4Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 848Triple Negative Breast Neoplasms 136Ovarian Neoplasms 55Colorectal Neoplasms 49Carcinoma, Non-Small-Cell Lung 47Neoplasms 43Prostatic Neoplasms 42Neoplasm Metastasis 42Lung Neoplasms 38Melanoma 30Carcinoma, Intraductal, Noninfiltrating 29Uterine Cervical Neoplasms 27Pancreatic Neoplasms 25Colonic Neoplasms 25Stomach Neoplasms 23Squamous Cell Carcinoma of Head and Neck 23Endometrial Neoplasms 23Carcinoma, Renal Cell 23Breast Carcinoma In Situ 22Esophageal Neoplasms 17Urinary Bladder Neoplasms 16Motor Activity 16Inflammatory Breast Neoplasms 16Head and Neck Neoplasms 16Small Cell Lung Carcinoma 15Sarcoma 14Breast Cancer Female 13Brain Neoplasms 12Anatomic Stage I Breast Cancer AJCC v8 12Gastrointestinal Neoplasms 11

Interventions

sacituzumab govitecan 1Safety 1Fulvestrant 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Advanced Breast Cancer × Breast × Clear all
NCT04524000 2026-04-08

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer

Novartis

Phase 2 Active not recruiting
24 enrolled
Breast

Advanced Breast Cancer

NCT07428655 2026-02-24

Acceptability and Feasibility of PSC Model of Serious Illness Communication

National Cancer Centre, Singapore

Phase NA Active not recruiting
28 enrolled
Breast

Advanced Breast Cancer

NCT06612203 2025-12-05

WIN-B

MedSIR

Phase 1/2 Active not recruiting
76 enrolled
Breast

Advanced Breast Cancer

NCT06926088 2025-04-13

CAMELIA

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting
500 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡